Marian and Geoff have taken part in clinical trials to test new treatments for Alzheimer’s disease. With new dementia ...

New blood tests could transform dementia diagnosis and care – and we know most people would take one. But what do NHS staff ...

Donanemab – one of the first drugs to slow down early-stage Alzheimer’s disease – will not be available on the NHS in ...

Alzheimer’s Research UK’s team of TCS London Marathon runners raised over £1million towards life-changing research to find a ...

You’ll get emails about our work and how you can take action to help us find a cure.

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

You’ll get emails about our work and how you can take action to help us find a cure.

PCA is caused by damage that builds up in the brain cells at the back of the brain. This is the part of our brain that processes information from our eyes, and allows us to make sense of what we are ...

Early and accurate diagnosis is the cornerstone of effective, person-centred care – and nowhere is this more important than in dementia. Spotting the signs early and getting a diagnosis can change ...

You’ll get emails about our work and how you can take action to help us find a cure.